This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Policy

Aug 1, 2025 - Notice from the Centers for Medicare & Medicaid Services making a point of contact correction to the June 20, 2025 information collection.
Source: Federal Register
Aug 1, 2025 - Announcement of the application process for the 340B Rebate Model Pilot Program and call for comments related to the structure and application process of the program. This program is voluntary and aims to test a rebate model on a select group of drugs for the purpose of understanding the merits and shortcomings of the rebate model. Drug manufacturers interested in participating should email 340BPricing@hrsa.gov by September 15, 2025. The program will start January 1, 2026 and run for 1 year. Comments are due September 2, 2025.
Source: Federal Register
Aug 1, 2025 - The Substance Abuse and Mental Health Services Administration is seeking comments on a proposed evaluation of the 988 Suicide and Crisis Lifeline and Crisis Services program with a specific look at the impact of the program on suicide and overdose morbidity and mortality. Comments are due within 30 days of publication.
Source: Federal Register
Jul 31, 2025 - Notice from the Centers for Medicare & Medicaid Services seeking comments on the following information collections: 1) Medicare Quality of Care Complaint Form; 2) Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts; and 3) Annual Notice of Change and Evidence of Coverage for Applicable Integrated Plans in States that Require Integrated Materials. Comments are due by September 29, 2025.
Source: Federal Register
Jul 30, 2025 - The U.S. Census Bureau is seeking comments on the proposed extension of an information collection titled "Generic Clearance for Questionnaire Pretesting Research." The clearance will be used to conduct pretesting of decennial, demographic, and economic census and survey questionnaires prior to fielding them. Comments are due by September 29, 2025.
Source: Federal Register
Jul 30, 2025 - Advisory notice from the Centers for Medicare and Medicaid Services to alert certain clinicians who are Qualifying APM participants (QPs) and have earned an Alternative Payment Model (APM) Incentive Payment that CMS does not have the current information needed to disburse the payment. Provides information to QPs on how to update their Medicare billing information so that CMS can disburse payments. All information should be sent to CMS by September 1, 2025.
Source: Federal Register
Jul 30, 2025 - Notice from the Health Resources and Services Administration (HRSA) seeking comments on revisions to an information collection regarding forms used by the National Health Service Corps (NHSC) and the Nurse Corps Scholarship and Loan Repayment Programs. The NHSC and Nurse Corps Interest Capture Form, is an optional form that a health profession student, licensed clinician, faculty member, clinical site administrator, or other interested individual can complete and submit to HRSA. The purpose of the form is to enable individuals and clinical sites to ask questions about the NHSC and/or Nurse Corps Scholarship and Loan Repayment Programs, and to provide their contact information so that HRSA may provide them with periodic program updates and other general information. Comments are due by September 29, 2025.
Source: Federal Register
Jul 29, 2025 - The Food and Drug Administration (FDA) has revoked Emergency Use Authorizations issued to Regeneron Pharmaceuticals, Inc., for REGEN-COV (casirivimab and imdevimab administered together); GlaxoSmithKline LLC for sotrovimab; Eli Lilly and Company for bebtelovimab; and AstraZeneca Pharmaceuticals LP for EVUSHELD (tixagevimab co-packaged with cilgavimab). These revocations are effective December 13, 2024.
Source: Federal Register
Jul 28, 2025 - Notice of final rule from the Department of Defense (DOD) Defense Health Agency (DHA) finalizing provisions published in two interim final rules (IFRs) that temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administration (FDA)-authorized expanded access (EA) programs when for the treatment of coronavirus disease 2019 (COVID-19) and permitted coverage of National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of COVID-19. Among other things, this rule discusses the DOD's decision not to make permanent the coverage of treatment use of investigational drugs under FDA EA programs while updating language for care associated with their administration and broadens the COVID-19 clinical trial benefit to include coverage of clinical trials sponsored or approved by any National Institutes of Health (NIH) Center or Institute to treat or prevent infectious diseases associated with a pandemic or epidemic. This rule is effective August 27, 2025.
Source: Federal Register
Jul 25, 2025 - Highlights the Rural Health Transformation Program, part of the One Big Beautiful Bill Act.
Source: The White House